Clinical Trial Update: A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating multiple dosing regimens of ABT-719 for preventing acute kidney injury in high-risk cardiac surgery patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• ABT-719

Snippet

Sponsor: AbbVie | Conditions: Acute Kidney Injury | Phase 2 | Status: COMPLETED